Identifying Patients with Eosinophilic Esophagitis

  • Rebecca L. Gunter
  • Luke M. FunkEmail author


Eosinophilic esophagitis (EoE) is an increasingly common esophageal disorder that presents with symptoms similar to those seen in patients with GERD, including dysphagia, heartburn, and atypical chest pain. The diagnosis is confirmed by EGD and esophageal mucosal biopsies demonstrating an elevated number of intraepithelial eosinophils. Treatment strategies include diet modification, oral topical steroid therapy, and proton pump inhibitors. Endoscopic balloon dilation is used to treat esophageal remodeling and structuring that can result from long-standing EoE. There is no role for surgical intervention.


GERD symptoms Atopy Topical steroids Dietary modification Esophageal fibrostenosis 


  1. 1.
    Dellon ES, Gonsalves N, Hirano I, Furuta GT, Liacouras CA, Katzka DA, et al. ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013;108:679–92; quiz 693CrossRefGoogle Scholar
  2. 2.
    Mansoor E, Cooper GS. The 2010-2015 prevalence of eosinophilic esophagitis in the USA: a population-based study. Dig Dis Sci. 2016;61:2928–34.CrossRefGoogle Scholar
  3. 3.
    Hirano I. 2015 David Y. Graham lecture: the first two decades of eosinophilic esophagitis-from acid reflux to food allergy. Am J Gastroenterol. 2016;111:770–6.CrossRefGoogle Scholar
  4. 4.
    Schoepfer AM, Straumann A, Panczak R, Coslovsky M, Kuehni CE, Maurer E, et al. Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis. Gastroenterology. 2014;147:1255–66. e21CrossRefGoogle Scholar
  5. 5.
    Dellon ES, Irani A-M, Hill MR, Hirano I. Development and field testing of a novel patient-reported outcome measure of dysphagia in patients with eosinophilic esophagitis. Aliment Pharmacol Ther. 2013;38:634–42.CrossRefGoogle Scholar
  6. 6.
    Grudell ABM, Alexander JA, Enders FB, Pacifico R, Fredericksen M, Wise JL, et al. Validation of the Mayo dysphagia questionnaire. Dis Esophagus. 2007;20:202–5.CrossRefGoogle Scholar
  7. 7.
    Safroneeva E, Straumann A, Coslovsky M, Zwahlen M, Kuehni CE, Panczak R, et al. Symptoms have modest accuracy in detecting endoscopic and histologic remission in adults with eosinophilic esophagitis. Gastroenterology. 2016;150:581–90. e4CrossRefGoogle Scholar
  8. 8.
    Miehlke S. Clinical features of eosinophilic esophagitis. Dig Dis. 2014;32:61–7.CrossRefGoogle Scholar
  9. 9.
    Richter JE. Current Management of Eosinophilic Esophagitis 2015. J Clin Gastroenterol. 2016;50:99–110.CrossRefGoogle Scholar
  10. 10.
    Kim HP, Vance RB, Shaheen NJ, Dellon ES. The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10:988–96. e5CrossRefGoogle Scholar
  11. 11.
    Peery AF, Cao H, Dominik R, Shaheen NJ, Dellon ES. Variable reliability of endoscopic findings with white-light and narrow-band imaging for patients with suspected eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2011;9:475–80.CrossRefGoogle Scholar
  12. 12.
    Hirano I, Moy N, Heckman MG, Thomas CS, Gonsalves N, Achem SR. Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut. 2013;62:489–95.CrossRefGoogle Scholar
  13. 13.
    Dellon ES, Cotton CC, Gebhart JH, Higgins LL, Beitia R, Woosley JT, et al. Accuracy of the eosinophilic esophagitis endoscopic reference score in diagnosis and determining response to treatment. Clin Gastroenterol Hepatol. 2016;14:31–9.CrossRefGoogle Scholar
  14. 14.
    Saffari H, Peterson KA, Fang JC, Teman C, Gleich GJ, Pease LF. Patchy eosinophil distributions in an esophagectomy specimen from a patient with eosinophilic esophagitis: implications for endoscopic biopsy. J Allergy Clin Immunol. 2012;130:798–800.CrossRefGoogle Scholar
  15. 15.
    Gonsalves N, Policarpio-Nicolas M, Zhang Q, Rao MS, Hirano I. Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis. Gastrointest Endosc. 2006;64:313–9.CrossRefGoogle Scholar
  16. 16.
    Gentile N, Katzka D, Ravi K, Trenkner S, Enders F, Killian J, et al. Oesophageal narrowing is common and frequently under-appreciated at endoscopy in patients with oesophageal eosinophilia. Aliment Pharmacol Ther. 2014;40:1333–40.CrossRefGoogle Scholar
  17. 17.
    Straumann A, Conus S, Degen L, Frei C, Bussmann C, Beglinger C, et al. Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2011;9:400–9. e1CrossRefGoogle Scholar
  18. 18.
    Hirano I, Aceves SS. Clinical implications and pathogenesis of esophageal remodeling in eosinophilic esophagitis. Gastroenterol Clin N Am. 2014;43:297–316.CrossRefGoogle Scholar
  19. 19.
    Kwiatek MA, Hirano I, Kahrilas PJ, Rothe J, Luger D, Pandolfino JE. Mechanical properties of the esophagus in eosinophilic esophagitis. Gastroenterology. 2011;140:82–90.CrossRefGoogle Scholar
  20. 20.
    Nicodème F, Hirano I, Chen J, Robinson K, Lin Z, Xiao Y, et al. Esophageal distensibility as a measure of disease severity in patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2013;11:1101–7. e1CrossRefGoogle Scholar
  21. 21.
    Collins MH. Histopathologic features of eosinophilic esophagitis. Gastrointest Endosc Clin N Am. 2008;18:59–71. viii – ixCrossRefGoogle Scholar
  22. 22.
    Winter HS, Madara JL, Stafford RJ, Grand RJ, Quinlan JE, Goldman H. Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis. Gastroenterology. 1982;83:818–23.PubMedGoogle Scholar
  23. 23.
    Brown LF, Goldman H, Antonioli DA. Intraepithelial eosinophils in endoscopic biopsies of adults with reflux esophagitis. Am J Surg Pathol. 1984;8:899–905.CrossRefGoogle Scholar
  24. 24.
    Attwood SE, Smyrk TC, Demeester TR, Jones JB. Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci. 1993;38:109–16.CrossRefGoogle Scholar
  25. 25.
    Straumann A, Spichtin HP, Bernoulli R, Loosli J, Vögtlin J. Idiopathic eosinophilic esophagitis: a frequently overlooked disease with typical clinical aspects and discrete endoscopic findings. Schweiz Med Wochenschr. 1994;124:1419–29.PubMedGoogle Scholar
  26. 26.
    Gonsalves N, Yang G-Y, Doerfler B, Ritz S, Ditto AM, Hirano I. Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology. 2012;142:1451–9.e1; quiz e14–5CrossRefGoogle Scholar
  27. 27.
    Lucendo AJ, Arias Á, González-Cervera J, Yagüe-Compadre JL, Guagnozzi D, Angueira T, et al. Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: a prospective study on the food cause of the disease. J Allergy Clin Immunol. 2013;131:797–804.CrossRefGoogle Scholar
  28. 28.
    Molina-Infante J, Arias A, Barrio J, Rodríguez-Sánchez J, Sanchez-Cazalilla M, Lucendo AJ. Four-food group elimination diet for adult eosinophilic esophagitis: a prospective multicenter study. J Allergy Clin Immunol. 2014;134:1093–9. e1CrossRefGoogle Scholar
  29. 29.
    Straumann A, Conus S, Degen L, Felder S, Kummer M, Engel H, et al. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology. 2010;139:1526–37, 1537.e1.CrossRefGoogle Scholar
  30. 30.
    Butz BK, Wen T, Gleich GJ, Furuta GT, Spergel J, King E, et al. Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis. Gastroenterology. 2014;147:324–33. e5CrossRefGoogle Scholar
  31. 31.
    Alexander JA, Jung KW, Arora AS, Enders F, Katzka DA, Kephardt GM, et al. Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2012;10:742–9. e1CrossRefGoogle Scholar
  32. 32.
    Molina-Infante J, Ferrando-Lamana L, Ripoll C, Hernandez-Alonso M, Mateos JM, Fernandez-Bermejo M, et al. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin Gastroenterol Hepatol. 2011;9:110–7.CrossRefGoogle Scholar
  33. 33.
    Cheng E, Zhang X, Huo X, Yu C, Zhang Q, Wang DH, et al. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut. 2013;62:824–32.CrossRefGoogle Scholar
  34. 34.
    Van Rhijn BD, Weijenborg PW, Verheij J, van den Bergh Weerman MA, Verseijden C, van den Wijngaard RMJGJ, et al. Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2014;12:1815–23.e2.CrossRefGoogle Scholar
  35. 35.
    Dellon ES, Kim HP, Sperry SLW, Rybnicek DA, Woosley JT, Shaheen NJ. A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease. Gastrointest Endosc. 2014;79:577–85.e4.CrossRefGoogle Scholar
  36. 36.
    Schoepfer AM, Gschossmann J, Scheurer U, Seibold F, Straumann A. Esophageal strictures in adult eosinophilic esophagitis: dilation is an effective and safe alternative after failure of topical corticosteroids. Endoscopy. 2008;40:161–4.CrossRefGoogle Scholar
  37. 37.
    Schoepfer AM, Gonsalves N, Bussmann C, Conus S, Simon H-U, Straumann A, et al. Esophageal dilation in eosinophilic esophagitis: effectiveness, safety, and impact on the underlying inflammation. Am J Gastroenterol. 2010;105:1062–70.CrossRefGoogle Scholar
  38. 38.
    Runge TM, Eluri S, Cotton CC, Burk CM, Woosley JT, Shaheen NJ, et al. Outcomes of esophageal dilation in eosinophilic esophagitis: safety, efficacy, and persistence of the Fibrostenotic phenotype. Am J Gastroenterol. 2016;111:206–13.CrossRefGoogle Scholar
  39. 39.
    Jacobs JW, Spechler SJ. A systematic review of the risk of perforation during esophageal dilation for patients with eosinophilic esophagitis. Dig Dis Sci. 2010;55:1512–5.CrossRefGoogle Scholar
  40. 40.
    Eluri S, Runge TM, Cotton CC, Burk CM, Wolf WA, Woosley JT, et al. The extremely narrow-caliber esophagus is a treatment-resistant subphenotype of eosinophilic esophagitis. Gastrointest Endosc. 2016;83:1142–8.CrossRefGoogle Scholar

Copyright information

© SAGES 2019

Authors and Affiliations

  1. 1.Department of SurgeryUniversity of Wisconsin Hospital and ClinicsMadisonUSA
  2. 2.Division of Minimally Invasive, Foregut, and Bariatric Surgery; Department of SurgeryUniversity of Wisconsin Hospital and ClinicsMadisonUSA

Personalised recommendations